About
Native Cardio, Inc. is a late-stage medical device company based in Naples, FL that develops minimally invasive solutions for postoperative atrial fibrillation (POAF). The company's Targeted Tissue Delivery System delivers precise, low-dose antiarrhythmic therapy and ultralow-energy cardioversion to restore normal heart rhythm without sedation or anesthesia. Native Cardio serves cardiac surgery centers, hospitals, and healthcare providers seeking cost-efficient alternatives to current POAF treatments.
Product
- Value proposition
- A late-stage medical device company delivering precise, low-dose therapy and painless cardioversion to transform cardiac care.
- Target customers
- cardiac surgery centers, hospitals, healthcare providers
Founders
- Joseph Pergolizzi — Co-founder and CEO
- Young D. Kim — Co-founder and Board Member
Products
Key features
Technologies
Target conditions
Care settings
Partnerships
Investors
News
- Management - NativeCardio, Inc. · 2025-06-13T00:00:00.000Z
- CardiaTec Biosciences – Cambridge Enterprise · 2025-04-22T07:00:39.000Z
- Heart disease is the world's biggest killer — this Cambridge Uni spinout is using AI to find new treatments | TechCrunch · 2024-09-10T04:00:00.000Z
- Press release: Ncardia launches Ncyte® Heart in a Box · 2025-01-27T12:01:54.000Z
- Chamber gets a $60M jolt to scale value-based cardiology care · 2026-02-04T00:00:00.000Z
- CardiaTec raises $6.5M Seed for cardiovascular drug discovery - Tech.eu · 2024-09-10T04:00:00.000Z
More links
Browse similar startups
Related startups
- NAVCES — Miami, FL
- nurturly peds — Boca Raton, FL
- Okaloosa Cardiology — Crestview, FL
- Oncoderm Labs — Miami, FL
- oncologic.ai — Orlando, FL
- OvaryIt — Tallahassee, FL
- Nava Benefits — New York City, NY
- Naviday Health — Boston, MA
- Navigate Maternity — Fort Wayne, IN
- NavigateHCR — San Diego, CA
- Navigation Benefits — Exton, PA
- Navwise — Cumming, GA
Profile updated Jul 29, 2026. Sources: native-cardio.com, nativecardio.com


